Significant efficacy benefit of IMBRUVICA® (ibrutinib) plus venetoclax versus acalabrutinib plus venetoclax in frontline treatment of patients with chronic lymphocytic leukaemia suggested by indirect treatment comparison
Amneal Receives U.S. FDA Approval for Prednisolone Acetate Ophthalmic Suspension
enGene Reports Second Quarter 2025 Financial Results and Provides Business Update
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
Cybin - Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution
U.S. Physical Therapy Presented at Investor Conferences
Compugen - Compugen to Present AI/ML Driven Predictive Computational Research at Upcoming International Scientific Conferences